Skip to main content

Table 2 Incidence rate ratios of the diagnosis of melanomaa (excludes Ontario)b–other controls

From: Incidence of cutaneous malignant melanoma by socioeconomic status in Canada: 1992–2006

 

All melanoma (n–105,681)

In situ

Invasive

IRR

P value

95 % CI

IRR

P value

95 % CI

IRR

P value

95 % CI

Proportion of Population by age/sex

 Male 20–29

1

  

1

  

1

  

 Male 30–39

0.99

0.01

(0.99–1.00)

0.98

0.01

(0.97–0.99)

1.00

0.25

(0.99–1.00)

 Male 40–49

0.99

0.00

(0.98–0.99)

0.98

0.01

(0.97–1.00)

0.99

0.01

(0.98–1.00)

 Male 50–59

0.99

0.01

(0.99–1.00)

0.99

0.48

(0.98–1.01)

0.99

0.02

(0.98–1.00)

 Male 60–69

1.00

0.42

(0.99–1.01)

1.00

0.99

(0.98–1.02)

0.99

0.34

(0.98–1.01)

 Male 70–79

1.01

0.00

(1.01–1.02)

1.01

0.32

(0.99–1.03)

1.01

0.00

(1.01–1.02)

 Male 80+

1.02

0.00

(1.02–1.03)

1.04

0.00

(1.02–1.06)

1.02

0.00

(1.01–1.03)

 Female 20–29

0.99

0.07

(0.99–1.00)

0.99

0.04

(0.97–1.00)

1.00

0.23

(0.99–1.00)

 Female 30–39

1.00

0.56

(0.99–1.00)

1.00

0.91

(0.99–1.01)

1.00

0.39

(0.99–1.00)

 Female 40–49

1.01

0.00

(1.01–1.02)

1.02

0.01

(1.00–1.03)

1.01

0.00

(1.01–1.02)

 Female 50–59

1.02

0.00

(1.01–1.03)

1.03

0.00

(1.01–1.04)

1.02

0.00

(1.01–1.02)

 Female 60–69

1.02

0.00

(1.01–1.03)

1.02

0.09

(1.00–1.04)

1.02

0.00

(1.01–1.03)

 Female 70–79

1.01

0.00

(1.01–1.02)

1.02

0.01

(1.00–1.03)

1.01

0.00

(1.01–1.02)

 Female 80+

1.01

0.00

(1.00–1.01)

1.00

0.70

(0.99–1.01)

1.01

0.00

(1.01–1.01)

Proportion of Population by race

 White

1

  

1

  

1

  

 Black

0.91

0.00

(0.88–0.95)

0.81

0.00

(0.73–0.89)

0.93

0.00

(0.90–0.97)

 East/Southeast Asian

0.91

0.00

(0.90–0.92)

0.88

0.00

(0.86–0.91)

0.92

0.00

(0.90–0.93)

 South Asian

0.88

0.00

(0.87–0.90)

0.90

0.00

(0.86–0.94)

0.88

0.00

(0.86–0.90)

 Other groups

0.98

0.09

(0.95–1.00)

0.99

0.69

(0.92–1.05)

0.98

0.16

(0.95–1.01)

  1. CI confidence interval, IRR incidence rate ratio
  2. aNegative binomial regressions on the incidence of diagnosed cases of melanoma by dissemination area (DA) and census year. Table presents regression results for control variables not reported in Table 1
  3. bCases of in situ melanoma are not available for Ontario in the Canadian Cancer Registry dataset in the Statistics Canada Research Data Centre so Ontario DAs are excluded from these regressions